Cannabinoid-induced relief of hypermotility in a rat model of the irritable bowel syndrome. Posted on May 18, 2019 by David “Cannabinoid-2 receptor agonists may be useful in treating intestinal motility disorders.” https://www.ncbi.nlm.nih.gov/pubmed/31094052 https://onlinelibrary.wiley.com/doi/abs/10.1111/nmo.13613